Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

VBI Vaccines Inc. VBIV NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
31/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

VBI Vaccines Inc. (VBIV) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 6 Buy.

VBIV Analyst Ratings

Buy
6
Ratings
6 Buy
Based on 6 analysts giving stock ratings to VBI Vaccines Inc. in the past 3 months
Rating breakdown
Buy
6 100%
100%
Buy
6 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

BBIO
BBIO
BridgeBio Pharma, Inc.
$77.93
+0.08%
 IMGN
IMGN
ImmunoGen, Inc.
$31.24
+0.02%
 AKRO
AKRO
Akero Therapeutics, Inc.
$54.65
+0.00%
 AUPH
AUPH
Aurinia Pharmaceuticals Inc.
$16.07
+0.06%
 ARDX
ARDX
Ardelyx, Inc.
$6.33
+0.16%
 OCGN
OCGN
Ocugen, Inc.
$1.80
+0.56%
 ALLO
ALLO
Allogene Therapeutics, Inc.
$2.28
-25.37%
 TNXP
TNXP
Tonix Pharmaceuticals Holding Corp.
$13.35
+2.85%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message